These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36206585)

  • 1. Associations between prescription and illicit stimulant and opioid use in the United States, 2015-2020.
    Shearer RD; Jones A; Howell BA; Segel JE; Winkelman TNA
    J Subst Abuse Treat; 2022 Dec; 143():108894. PubMed ID: 36206585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misuse of Prescription and Illicit Drugs in Middle Adulthood in the Context of the Opioid Epidemic.
    Faller RW; Erausquin JT; McCoy TP
    Subst Use Misuse; 2021; 56(2):333-337. PubMed ID: 33325317
    [No Abstract]   [Full Text] [Related]  

  • 3. National polydrug use patterns among people who misuse prescription opioids and people who use heroin. Results from the National Household Survey on Drug Use and Health.
    Bobashev GV; Warren LK
    Drug Alcohol Depend; 2022 Sep; 238():109553. PubMed ID: 35905594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription opioid use and misuse among adolescents and young adults in the United States: A national survey study.
    Hudgins JD; Porter JJ; Monuteaux MC; Bourgeois FT
    PLoS Med; 2019 Nov; 16(11):e1002922. PubMed ID: 31689290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in Use/Misuse of Specific Illicit and Prescription Drugs among Sexual Minority Adults in a National Sample.
    Schuler MS; Collins RL; Ramchand R
    Subst Use Misuse; 2022; 57(3):461-471. PubMed ID: 35067155
    [No Abstract]   [Full Text] [Related]  

  • 6. The epidemiology of prescription fentanyl misuse in the United States.
    Schepis TS; McCabe VV; Boyd CJ; McCabe SE
    Addict Behav; 2019 Sep; 96():89-93. PubMed ID: 31063940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vital Signs: Characteristics of Drug Overdose Deaths Involving Opioids and Stimulants - 24 States and the District of Columbia, January-June 2019.
    O'Donnell J; Gladden RM; Mattson CL; Hunter CT; Davis NL
    MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(35):1189-1197. PubMed ID: 32881854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonmedical use of prescription opioids and stimulants among student pharmacists.
    Lord S; Downs G; Furtaw P; Chaudhuri A; Silverstein A; Gammaitoni A; Budman S
    J Am Pharm Assoc (2003); 2009; 49(4):519-28. PubMed ID: 19589764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is age of onset and duration of stimulant therapy for ADHD associated with cocaine, methamphetamine, and prescription stimulant misuse?
    McCabe SE; Figueroa O; McCabe VV; Schepis TS; Schulenberg JE; Veliz PT; Werner KS; Wilens TE
    J Child Psychol Psychiatry; 2024 Jan; 65(1):100-111. PubMed ID: 37062713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocaine or Methamphetamine Use During Young Adulthood Following Stimulant Use for Attention-Deficit/Hyperactivity Disorder During Adolescence.
    McCabe SE; Schulenberg JE; Wilens TE; Schepis TS; McCabe VV; Veliz PT
    JAMA Netw Open; 2023 Jul; 6(7):e2322650. PubMed ID: 37432689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signals of increasing co-use of stimulants and opioids from online drug forum data.
    Sarker A; Al-Garadi MA; Ge Y; Nataraj N; Jones CM; Sumner SA
    Harm Reduct J; 2022 May; 19(1):51. PubMed ID: 35614501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive multivariate model of biopsychosocial factors associated with opioid misuse and use disorder in a 2017-2018 United States national survey.
    Montiel Ishino FA; McNab PR; Gilreath T; Salmeron B; Williams F
    BMC Public Health; 2020 Nov; 20(1):1740. PubMed ID: 33208132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant misuse among youth.
    LaBossier NJ; Hadland SE
    Curr Probl Pediatr Adolesc Health Care; 2022 Sep; 52(9):101265. PubMed ID: 36184490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulant use for self-management of pain among safety-net patients with chronic non-cancer pain.
    Beliveau CM; McMahan VM; Arenander J; Angst MS; Kushel M; Torres A; Santos GM; Coffin PO
    Subst Abus; 2022; 43(1):179-186. PubMed ID: 33798030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription Opioid Use Disorder Among Adults Reporting Prescription Opioid Use With or Without Misuse in the United States.
    Han B; Jones CM; Einstein EB; Dowell D; Compton WM
    J Clin Psychiatry; 2024 Jul; 85(3):. PubMed ID: 39028542
    [No Abstract]   [Full Text] [Related]  

  • 17. Are prescription misuse and illicit drug use etiologically distinct? A genetically-informed analysis of opioids and stimulants.
    Dash GF; Martin NG; Agrawal A; Lynskey MT; Slutske WS
    Psychol Med; 2022 Oct; 52(14):3176-3183. PubMed ID: 33455586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unmet Need in Relation to Mental Healthcare and Past-Month Drug Use among People with Mental Illness in the United States.
    Reid BE; Palamar JJ
    J Psychoactive Drugs; 2022; 54(3):241-249. PubMed ID: 34402414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between stimulant use and return to illicit opioid use following initiation onto medication for opioid use disorder.
    Foot C; Korthuis PT; Tsui JI; Luo SX; Chan B; Cook RR
    Addiction; 2024 Jan; 119(1):149-157. PubMed ID: 37712113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in the prevalence of stimulant misuse in the United States: 2015-2019.
    McHugh RK; Korte FM; Bichon JA; Weiss RD
    Am J Addict; 2024 May; 33(3):283-289. PubMed ID: 37924248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.